scispace - formally typeset
A

Anna Moshnikova

Researcher at University of Rhode Island

Publications -  42
Citations -  1663

Anna Moshnikova is an academic researcher from University of Rhode Island. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 19, co-authored 35 publications receiving 1328 citations. Previous affiliations of Anna Moshnikova include Russian Academy of Sciences & University of Virginia.

Papers
More filters
Journal ArticleDOI

Family of pH (low) insertion peptides for tumor targeting

TL;DR: A library of 16 rationally designed pHLIP variants is reported on, showing how the tuning of the biophysical properties of peptide–lipid bilayer interactions alters tumor targeting, distribution in organs, and blood clearance.
Journal ArticleDOI

Probe for the measurement of cell surface pH in vivo and ex vivo

TL;DR: A probe that uses a pH low insertion peptide to locate a pH-sensing dye at acidic cell surfaces is developed and it is found that the probe can measure surface pH, which is correlated with tumor aggressiveness and is sensitive to cell glycolytic activity.
Journal ArticleDOI

pHLIP peptide targets nanogold particles to tumors

TL;DR: In this article, a method for the preferential targeting of gold nanoparticles to a tumor in a mouse model is described, which is based on the use of the pH Low Insertion Peptide (pHLIP), which targets various imaging agents to acidic tumors.
Journal Article

pHLIP Peptide Targets Nanogold Particles to Tumors

TL;DR: The pHLIP technology can substantially improve the delivery of gold nanoparticles to tumors by providing specificity of targeting, enhancing local concentration in tumors, and distributing nanoparticles throughout the entire tumor mass where they remain for an extended period (several days), which is beneficial for radiation oncology and imaging.
Journal ArticleDOI

Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II

TL;DR: The crystal structure of Ras in complex with the Ras binding domain (RBD) of NORE1A/RAPL is described and it is demonstrated that the enlarged interface provides a rationale for an exceptionally long lifetime of the complex.